Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection

Acquired immune deficiency syndrome (AIDS) has prevailed over the last 30 years. Although highly active antiretroviral therapy (HAART) has decreased mortality and efficiently controlled the progression of disease, no vaccine or curative drugs have been approved until now. A viral inactivator is expe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinling, Cao, Miao, Wu, Yanling, Xu, Wei, Wang, Qian, Ying, Tianlei, Lu, Lu, Jiang, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036483/
https://www.ncbi.nlm.nih.gov/pubmed/33807292
http://dx.doi.org/10.3390/molecules26071964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036483/
https://www.ncbi.nlm.nih.gov/pubmed/33807292
http://dx.doi.org/10.3390/molecules26071964

Ejemplares similares